Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
mg decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 mg » 5 mm (Expand Search)
Showing 361 - 380 results of 20,601 for search '(( 50 ((a decrease) OR (((nn decrease) OR (mean decrease)))) ) OR ( 5 mg decrease ))', query time: 0.54s Refine Results
  1. 361
    Participants with virologic suppression or failure at week 24.

    Participants with virologic suppression or failure at week 24. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 362
    Socio-demographic and clinical characteristics of HIV-infected treatment-naïve individuals initiating ART.

    Socio-demographic and clinical characteristics of HIV-infected treatment-naïve individuals initiating ART. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 363
    Consolidated Standards of Reporting Trials flow diagram for participants in the trial.

    Consolidated Standards of Reporting Trials flow diagram for participants in the trial. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 364
    Changes in baseline CD4 count through week 12 and week 24 according to the linear regression model.

    Changes in baseline CD4 count through week 12 and week 24 according to the linear regression model. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 365
    Most frequently experienced adverse events among study participants by treatment arms from baseline through week 24.

    Most frequently experienced adverse events among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 366
    Cumulative incidence of mortality and loss to follow-up (LTF) among study participants by treatment arms from baseline through week 24.

    Cumulative incidence of mortality and loss to follow-up (LTF) among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 367
    Cumulative incidence of morbidity, loss to follow-up (LTF) and mortality among study participants by treatment arms from baseline through week 24.

    Cumulative incidence of morbidity, loss to follow-up (LTF) and mortality among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 368
    Median changes in CD4 count, platelet activation, immune activation, and exhaustion markers from baseline through week 12 and week 24.

    Median changes in CD4 count, platelet activation, immune activation, and exhaustion markers from baseline through week 12 and week 24. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 369
    Fig 5 -

    Fig 5 - by Saeed El-Ashram (710370)

    Published 2021
    Save to List
    Saved in:
  10. 370
    Fig 5 -

    Fig 5 - by Wenping Dong (3854437)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  11. 371
    The primers related to FAM50A.

    The primers related to FAM50A. by Longhai Li (4052044)

    Published 2025
    “…Knockdown of FAM50A decreased cell proliferation ability, the proportion of EdU positive cells, and the number of CRC cell colonies, whereas overexpressing FAM50A promoted proliferative phenotypes. …”
    Save to List
    Saved in:
  12. 372
    Fig 9 -

    Fig 9 - by Dennis Ochola (11626912)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  13. 373
    Fig 7 -

    Fig 7 - by Dennis Ochola (11626912)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  14. 374
    Fig 4 -

    Fig 4 - by Dennis Ochola (11626912)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  15. 375
    Fig 5 -

    Fig 5 - by Dennis Ochola (11626912)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  16. 376
    Complete data.

    Complete data. by Jan Víteček (11434774)

    Published 2024
    “…The rt-PA became increasingly less efficient for clots larger than 50 μl at a clinically relevant concentration of 1.3 mg/l. …”
    Save to List
    Saved in:
  17. 377
    Fig 4 -

    Fig 4 - by Jan Víteček (11434774)

    Published 2024
    “…The rt-PA became increasingly less efficient for clots larger than 50 μl at a clinically relevant concentration of 1.3 mg/l. …”
    Save to List
    Saved in:
  18. 378
    THRα/β EC<sub>50</sub> values and selectivity of test compounds.

    THRα/β EC<sub>50</sub> values and selectivity of test compounds. by Xuan G. Luong (9761423)

    Published 2020
    Save to List
    Saved in:
  19. 379
    Proportion of L3 recovered from forages.

    Proportion of L3 recovered from forages. by Katy A. Martin (9216905)

    Published 2025
    Save to List
    Saved in:
  20. 380
    Multiple logistic regression model exploring factors associated with >50% seizures reduction at month 4.

    Multiple logistic regression model exploring factors associated with >50% seizures reduction at month 4. by Michel Mandro (2637532)

    Published 2020
    Save to List
    Saved in:

Search Tools: